Importance of P-glycoprotein at blood–tissue barriers
Top Cited Papers
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (8) , 423-429
- https://doi.org/10.1016/j.tips.2004.06.002
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Transporters and Renal Drug EliminationAnnual Review of Pharmacology and Toxicology, 2004
- MDR1 Haplotypes Modify BEN Disease Risk: A Study in Bulgarian Patients with Balkan Endemic Nephropathy Compared to Healthy ControlsNephron Experimental Nephrology, 2004
- MDR1 Ala893 Polymorphism Is Associated with Inflammatory Bowel DiseaseAmerican Journal of Human Genetics, 2003
- Polymorphism in the P-glycoprotein drug transporter MDR1 genePharmacogenetics, 2003
- Role of P-Glycoprotein in PharmacokineticsClinical Pharmacokinetics, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- The Gut as a Barrier to Drug AbsorptionClinical Pharmacokinetics, 2001
- Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by RifampinJournal of Biological Chemistry, 2001
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995